Recent Company News

• 03:12 PM ET May 08, 2026
  

  Genmab holder orbis Investment Management discloses increased stake of 5.08% (DKK 1641.50, 0.00)

• 02:34 PM ET May 08, 2026
  

  FDA issues approval for Bizengri (zenocutuzumab-zbco) for treatment of NRG1 fusion-positive cholangiocarcinoma

• 08:48 AM ET May 06, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:05 PM ET May 07, 2026
  

  Transcript Intelligence: Genmab Q1 Earnings Themes

• 04:05 PM ET May 07, 2026
  

  Transcript Intelligence: Genmab Q1 Earnings Guidance

• 04:05 PM ET May 07, 2026
  

  Transcript Intelligence: Genmab Q1 Earnings Q&A

• 11:04 AM ET May 07, 2026
  

  Genmab reports Q1 revenue $896M vs FactSet $905.8M [14 est, $820-1.02B] (DKK 1758.50, 0.00)

• 05:46 PM ET May 06, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market